| NewCardio, Inc. is a cardiac diagnostic technology provider which focuses on the research, development and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular diseases, as well as the cardiac safety assessment of drugs under development. The company engages in development of three solutions through 3D platform technology, which includes QTinno, CardioBip and my3KG. The QTinno is an automated cardiac safety solution that streamlines the process for meeting the early phase cardiac safety analysis. |
|
